Fox Chase Cancer Center
SABCS Highlights on HR+ HER2- mBC: The All-Oral Regimen of Tesetaxel+Reduced Dose of Cape, Survival Data With Exemestane + Entinostat in AI-Resistant Disease
By
Fox Chase Cancer Center
FEATURING
Jennifer Matro
By
Fox Chase Cancer Center
FEATURING
Jennifer Matro
Login to view comments.
Click here to Login
